Novolin R

Product manufactured by Tya Pharmaceuticals

Application Nr Approved Date Route Status External Links
NDA019938 1991-06-25 Subcutaneous OTC Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Novolin R Is A Short-Acting Recombinant Human Insulin Indicated To Improve Glycemic Control In Adults And Children With Diabetes Mellitus ( ). 1 1.1 Treatment Of Diabetes Mellitus Novolin R Is Indicated To Improve Glycemic Control In Adults And Children With Diabetes Mellitus.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Insulin Human

Comments